Erik Greb

Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.

News

Consensus document reviews determination of brain death

Author:: Erik Greb

Publish date: August 12, 2020

The recommendations are the minimum criteria for the determination of brain death or death by neurologic criteria.

News

Cardiovascular risk factors tied to midlife cognitive decline

Author:: Erik Greb

Publish date: July 17, 2020

Hypertension, diabetes, and smoking can affect cognition at an age much younger than previously believed.

News

Less REM sleep tied to higher mortality

Author:: Erik Greb

Publish date: July 15, 2020

Less REM sleep is associated with an increased risk for death in middle-aged and older adults.

News

Can DBS in early Parkinson’s disease reduce disease progression?

Author:: Erik Greb

Publish date: July 8, 2020

Compared with standard treatment, DBS plus drug therapy appears to reduce the need for polypharmacy.

News

Migraine is often a deciding factor in pregnancy planning

Author:: Erik Greb

Publish date: July 1, 2020

Among women with migraine, those who were younger, had menstrual migraine, or had chronic migraine were more likely to decide to not become pregnan...

News

Consistent effects for galcanezumab in cluster headache

Author:: Erik Greb

Publish date: June 25, 2020

Most patients whose PGI-I score improved in one cluster bout also improved in a subsequent bout.

News

Headache may predict clinical evolution of COVID-19

Author:: Erik Greb

Publish date: June 22, 2020

Headache onset could occur during the presymptomatic or symptomatic phase of COVID-19 and could resemble tension-type or migraine headache.

News

Adding CGRP to Botox is safe and effective for migraine prevention

Author:: Erik Greb

Publish date: June 19, 2020

Adjunctive preventive therapy with a calcitonin...

News

Few patients with migraine clear barriers to optimal care

Author:: Erik Greb

Publish date: June 16, 2020

Less than 8% of patients with episodic migraine and less than 2% of patients with chronic migraine were able to overcome four key treatment barrier...

News

Function in MS may vary significantly within EDSS scores

Author:: Erik Greb

Publish date: June 8, 2020

Mean normalized velocity of preferred walking speed may vary by more than 20% within EDSS groups and overlap by more than 20% between groups.

News

Telerehabilitation may be effective in MS

Author:: Erik Greb

Publish date: June 1, 2020

Patients with MS may achieve equivalent benefits and increased cost savings with telerehabilitation, compared with outpatient rehabilitation.

News

Nilotinib is safe in moderate and advanced Parkinson’s disease

Author:: Erik Greb

Publish date: May 29, 2020

Although the drug is safe and tolerable, it penetrates the brain poorly and does not change levels of dopamine or its metabolites.

News

Chronic migraine is associated with changes in the amygdala

Author:: Erik Greb

Publish date: May 27, 2020

Changes in the volume and connectivity of the amygdala are associated with headache frequency and affective states.

News

AAN publishes ethical guidance on patient care during the pandemic

Author:: Erik Greb

Publish date: May 20, 2020

The guidance reviews adaptations to inpatient and outpatient care and indicates the need for protocols to allocate scarce medical resources.

News

New research confirms the efficacy and safety of onasemnogene abeparvovec for SMA

Author:: Erik Greb

Publish date: May 19, 2020

Three investigations indicate that the treatment allows children, including those who are presymptomatic, to achieve and maintain motor milestones....